5-{[4-(4-Bromophenyl)-1,3-thiazol-2-yl]methyl}-3-(4-fluorophenyl)-1,2,4-oxadiazole结构式
|
常用名 | 5-{[4-(4-Bromophenyl)-1,3-thiazol-2-yl]methyl}-3-(4-fluorophenyl)-1,2,4-oxadiazole | 英文名 | 5-{[4-(4-Bromophenyl)-1,3-thiazol-2-yl]methyl}-3-(4-fluorophenyl)-1,2,4-oxadiazole |
|---|---|---|---|---|
| CAS号 | 1112446-93-1 | 分子量 | 416.3 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C18H11BrFN3OS | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 5-{[4-(4-Bromophenyl)-1,3-thiazol-2-yl]methyl}-3-(4-fluorophenyl)-1,2,4-oxadiazole |
|---|
| 分子式 | C18H11BrFN3OS |
|---|---|
| 分子量 | 416.3 |
| InChIKey | BSDNDBZOWVUOKI-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC=C1C2=NOC(=N2)CC3=NC(=CS3)C4=CC=C(C=C4)Br)F |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|